Title: Associate Director of Drug Substance
Company: Otsuka Pharmaceutical Companies
Location: Irvine, California, United States
Namin Kang, associate director of drug substance at Otsuka Pharmaceutical Companies, has been recognized by Marquis Who’s Who Top Healthcare Professionals for dedication, achievements, and leadership in chemistry.
With over two decades of experience, Dr. Kang has established himself as a leader in the field of chemistry. He embarked on his academic journey by obtaining a bachelor’s degree in South Korea before pursuing a Master of Science in polymer chemistry from Pusan National University, South Korea, in 2000. Following this, he continued his academic endeavors, earning a Ph.D. in synthetic, organic, and medicinal chemistry from the Florida Institute of Technology in 2007.
Dr. Kang’s career spans various esteemed positions, showcasing his expertise and versatility. He has served as a research scientist at KOSEF from 2000 to 2002, followed by roles as a synthetic organic chemist at Olon Ricerca Bioscience from 2008 to 2011, and subsequently as a scientist at American Radiolabeled Chemicals, Inc. in 2008. He continued to advance, holding positions as a scientist at Olon Ricerca from 2011 to 2013, a senior chemist at Edwards Lifesciences from 2013 to 2015, and a research and development manager at Aspira Scientific from 2015 to 2016. Dr. Kang further expanded his expertise as a senior scientist at Moravek Biochemicals Inc. from 2017 to 2018 before assuming his current role as associate director of drug substance at Otsuka Pharmaceutical Companies in 2018.
In light of his impressive undertakings, Dr. Kang has accrued several accolades throughout his career. He was recognized as a key contributor to innovative pharmaceutical development and was presented with awards for his contributions to scientific research. He was also selected for inclusion in multiple editions of prestigious academic publications for his groundbreaking work in synthetic and medicinal chemistry. Looking ahead, Dr. Kang remains dedicated to leveraging his wealth of experience and expertise to drive further innovations in pharmaceuticals and contribute positively to the advancement of the field for years to come.
For more information, please visit:
Otsuka Pharmaceutical Companies
Contact Dr. Kang:
